Book description
This guide explains how to apply health economic evaluation techniques to both clinical trial and non-clinical trial data. Through a simple, applied approach using examples and SAS software, the book helps statisticians and researchers in health economics assess cost-effectiveness. It covers trial design, case report form design, quality of life measures, sample sizes, submissions to regulatory authorities for reimbursement, Markov models, cohort models, and decision trees. Examples and case studies are provided at the end of each chapter.
Table of contents
- Front Cover (1/3)
- Front Cover (2/3)
- Front Cover (3/3)
- Contents (1/2)
- Contents (2/2)
- Preface
- Author
- Acronyms
- Chapter 1: Introduction to Economic Evaluation (1/5)
- Chapter 1: Introduction to Economic Evaluation (2/5)
- Chapter 1: Introduction to Economic Evaluation (3/5)
- Chapter 1: Introduction to Economic Evaluation (4/5)
- Chapter 1: Introduction to Economic Evaluation (5/5)
- Chapter 2: Health Economic Evaluation Concepts (1/6)
- Chapter 2: Health Economic Evaluation Concepts (2/6)
- Chapter 2: Health Economic Evaluation Concepts (3/6)
- Chapter 2: Health Economic Evaluation Concepts (4/6)
- Chapter 2: Health Economic Evaluation Concepts (5/6)
- Chapter 2: Health Economic Evaluation Concepts (6/6)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (1/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (2/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (3/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (4/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (5/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (6/7)
- Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (7/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (1/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (2/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (3/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (4/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (5/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (6/7)
- Chapter 4: Analysing Cost Data Collected in a Clinical Trial (7/7)
- Chapter 5: Quality of Life in Economic Evaluation (1/7)
- Chapter 5: Quality of Life in Economic Evaluation (2/7)
- Chapter 5: Quality of Life in Economic Evaluation (3/7)
- Chapter 5: Quality of Life in Economic Evaluation (4/7)
- Chapter 5: Quality of Life in Economic Evaluation (5/7)
- Chapter 5: Quality of Life in Economic Evaluation (6/7)
- Chapter 5: Quality of Life in Economic Evaluation (7/7)
- Chapter 6: Modelling in Economic Evaluation (1/6)
- Chapter 6: Modelling in Economic Evaluation (2/6)
- Chapter 6: Modelling in Economic Evaluation (3/6)
- Chapter 6: Modelling in Economic Evaluation (4/6)
- Chapter 6: Modelling in Economic Evaluation (5/6)
- Chapter 6: Modelling in Economic Evaluation (6/6)
- Chapter 7: Sensitivity Analyses (1/6)
- Chapter 7: Sensitivity Analyses (2/6)
- Chapter 7: Sensitivity Analyses (3/6)
- Chapter 7: Sensitivity Analyses (4/6)
- Chapter 7: Sensitivity Analyses (5/6)
- Chapter 7: Sensitivity Analyses (6/6)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (1/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (2/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (3/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (4/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (5/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (6/7)
- Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (7/7)
- Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (1/3)
- Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (2/3)
- Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (3/3)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (1/6)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (2/6)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (3/6)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (4/6)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (5/6)
- Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (6/6)
- Chapter 11: The Reimbursement Environment (1/3)
- Chapter 11: The Reimbursement Environment (2/3)
- Chapter 11: The Reimbursement Environment (3/3)
- References (1/2)
- References (2/2)
- Bibliography (1/2)
- Bibliography (2/2)
- Back Cover
Product information
- Title: Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
- Author(s):
- Release date: November 2015
- Publisher(s): Chapman and Hall/CRC
- ISBN: 9781466505483
You might also like
book
Methods and Applications of Statistics in Clinical Trials, Volume 2: Planning, Analysis, and Inferential Methods
Methods and Applications of Statistics in Clinical Trials, Volume 2: Planning, Analysis, and Inferential Methods includes …
book
Value Based Health Care: Linking Finance and Quality
Value-Based Health Care Linking Finance and Quality Yosef D. Dlugacz Value-Based Health Care? Value-Based Health Care?concisely …
book
Real World Health Care Data Analysis
Discover best practices for real world data research with SAS code and examples Real world health …
book
The Funding of Biopharmaceutical Research and Development
The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of …